Relay Therapeutics Inc
NASDAQ:RLAY
Relay Therapeutics Inc
NASDAQ:RLAY
Price:
14.81
USD
4%
Market Closed
Market Cap:
$2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
US |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
UK |
|
International Paper Co
NYSE:IP
|
US |
|
Unilever PLC
LSE:ULVR
|
UK |
|
M
|
M-Tron Industries Inc
AMEX:MPTI
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
Smoore International Holdings Ltd
HKEX:6969
|
CN |
|
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
CA |
|
Companhia Energetica de Minas Gerais CEMIG
NYSE:CIG.C
|
BR |
|
M
|
Mitsubishi Estate Logistics REIT Investment Corp
TSE:3481
|
JP |
|
A
|
Amrize AG
SIX:AMRZ
|
US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
US |
|
E
|
Equity LifeStyle Properties Inc
NYSE:ELS
|
US |
|
Macrotech Developers Ltd
NSE:LODHA
|
IN |
|
Investor AB
STO:INVE B
|
SE |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
US |
|
Tenaris SA
MIL:TEN
|
LU |
|
Sysco Corp
NYSE:SYY
|
US |
|
Amada Co Ltd
TSE:6113
|
JP |
Multiples-Based Value
The Multiples-Based Value for Relay Therapeutics Inc (RLAY) under the Base Case is hidden
USD.
Compared with the current market price of 14.81 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RLAY Multiples-Based Value
LOCKED
